Investigators

Summary

Norman Wolmark, MD, has spent decades conducting groundbreaking research and early clinical trials in the treatment of breast and bowel cancers.  Many of his early studies were conducted at the University of Pittsburgh alongside the late Dr. Bernard Fisher. Dr. Wolmark serves as Chairman of the NSABP Foundation and as Group Chair and Contact Principal Investigator of the NCI-funded NRG Oncology research organization, which combined the legacy National Surgical Adjuvant Breast and Bowel Project (NSABP), Radiation Therapy Oncology Group (RTOG), and Gynecologic Oncology Group (GOG). Dr. Wolmark is a member of a number of professional associations and organizations, including the American Society of Clinical Oncology, the American Association of Cancer Research, and the American Surgical Association. He has authored more than 400 scientific publications and has served on the editorial boards of publications such as the Journal of Clinical Oncology, the Journal of Surgical Oncology, and Clinical Breast Cancer, as well as having served as a reviewer for journals such as the Annals of Internal Medicine, Breast Cancer Research and Treatment, Cancer Research, and the New England Journal of Medicine. Dr. Wolmark lectures internationally and has been recognized for his invaluable contributions to practice-changing research.